Fran Boyle
speaker
110 appearances
2 recordings
1 series
first heard Nov 2016
last heard Jun 2018
Fran Boyle’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
Hello, Norman.
It's a very exciting day.
Well, I think chemotherapy is fantastic if you need it, and it's fantastic if it's going to work for you.
But if it isn't, then it's absolutely something to be avoided.
And we think that the group that we're looking at here are people with what we call an intermediate risk cancer.
not a really high-risk cancer, not a really low-risk cancer, but that sort of grey zone or the ones where you sit on the fence and ponder,
And what's fantastic is that additional information can help you work out who really is going to benefit.
So these would be women who've had surgery to remove a lump or a mastectomy.
They've had some lymph nodes sampled under the arm.
And they've had some standard pathology tests that we do all around the country.
So they've got hormonal breast cancer, which you can tell from staining the slides.
Meaning
That's exactly right.
So that some of the growth of the cancer is being driven by estrogen.
And we know that hormone blocking drugs are very helpful for that group of women.
So that's a standard test we would do here.
It also is the kind of cancer that doesn't need Herceptin because it doesn't have that extra lock and key of the HER2 and it isn't in the lymph nodes.
So this is actually a pretty common kind of breast cancer we would pick up, particularly in older women who are in the screening age groups and are having breast screened so their cancers are picked up at that earlier stage.
So what the test does is it takes a piece of that pathology sample and
in our case, sends it to America.
Showing 1–20 of 110 · page 1 of 6
Next →